Why does Ki-67 expression matter for stem cell target validation?

Ki-67 is a nuclear protein expressed exclusively in dividing cells, and its detection via immunofluorescence confirms active proliferation. Increased Ki-67 expression in engineered mesenchymal stem cells indicates suitability for neurotherapeutic applications by validating cellular fitness and transgene functionality. This measurement supports target confidence by linking proliferation to therapeutic potential.

How does isolating the proliferation variable fit the discovery pipeline?

Isolating proliferation as a dependent variable allows researchers to assess whether transgene expression correlates with cellular division capacity. By fixing, permeabilizing, and staining for Ki-67, the assay controls for nonspecific binding and focuses on nuclear-specific signal. This variable isolation supports mechanistic de-risking in early discovery by clarifying the functional state of engineered stem cells.

What quantitative measurements does high-content screening enable for proliferation assessment?

High-content screening captures fluorescent signals from DAPI, GFP, and Cy3 channels to quantify nuclear proliferation, transgene expression, and antibody binding. The system calculates intensity thresholds using negative controls to ensure specific signal detection in positive wells. These quantitative outputs enable standardized comparison across conditions and support data-driven go/no-go decisions.

Why do replication requirements matter for cross-functional collaboration in stem cell characterization?

Replicate washing steps (three times for seven minutes each) and standardized incubation conditions ensure assay reproducibility across users and laboratories. Consistent protocols for fixation, permeabilization, and antibody incubation reduce variability in proliferation signal detection. This standardization enables reliable data sharing between discovery, preclinical, and manufacturing teams.

What statistical analysis capabilities are required before implementing this proliferation assay?

Implementation requires threshold setting based on negative control wells to distinguish specific signal from background, using auto-exposure and intensity level calculations. The same threshold must be applied to positive wells for comparative analysis, ensuring statistical validity. These capabilities enable reliable quantification of proliferation marker expression and support confidence in assay results.

Characterization of Genetically Engineered Mesenchymal Stem Cells for Neurotherapeutic Applications

JoVE Encyclopedia of Experiments

Neurowetenschap

0 weergaven • 3:23 min • August 7th, 2025

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Begin with transgenic mouse mesenchymal stem cells—multipotent cells derived from bone marrow.

The cells are engineered to express GFP and therapeutic neurotrophic factors that support neuronal growth and survival.

Wash the cells with buffer and fix them to preserve cellular integrity.

Wash again with buffer, then add a solution to permeabilize the cell and nuclear membranes and block non-specific binding sites.

Introduce primary antibodies targeting a cell proliferation marker protein expressed exclusively in the nucleus of dividing cells.

Wash with buffer to remove unbound antibodies.

Add fluorophore-conjugated secondary antibodies targeting the primary antibodies and a DNA-binding dye to counterstain the nuclei.

Wash with buffer to remove unbound reagents.

Load the plate into the high-content screening system and capture images to detect fluorescent signals.

Expression of the cell proliferation marker indicates active cell division, suggesting the suitability of the transgenic cells for neurotherapeutic applications.

To carry out a Ki-67 cell proliferation assay, use 0.1 molar phosphate buffer to rinse the cell cultures for one minute. After repeating the wash, use 4% Paraformaldehyde, or PFA, at room temperature for 20 minutes to fix the cultures.

Following fixation, remove the PFA and use PBS to rinse the wells three times for seven minutes each. After blocking the cells according to the text protocol, apply 100 microliters of primary antibody solution to each well. Cover the plate and incubate at 4 degrees Celsius overnight.

After washing the cells three times for seven minutes for each wash, apply secondary antibody, place the cells in the dark, and incubate at room temperature for 90 minutes. Following another three washes, cover the plate and store it at 4 degrees Celsius until imaging.

To perform automated imaging, load the immuno-labeled plate into the HCS system and allow the plate to equilibrate for 20 minutes. Open the HCS system image acquisition and analysis software. Choose the acquisition settings for the 10X objective using camera binning at 1 and gain setting of 2.

Gerelateerde video's

0 Bekeken

Laatst bijgewerkt: 1 augustus 2026

Characterization of Genetically Engineered Mesenchymal Stem Cells for Neurotherapeutic Applications

Overzicht

Belangrijkste Studiecomponenten

Wetenschapsgebied

Achtergrond

Doel van de Studie

Gebruikte Methoden

Belangrijkste Resultaten

Conclusies

Veelgestelde Vragen

Executive Industry Relevance

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

Screening & Assay Development

Translational & Preclinical Research

Pipeline & Workflow Integration

Operational & Enterprise Impact

Implementation Considerations

Biopharma FAQs

Isolatie en karakterisering van mesenchymale stromale cellen uit menselijke navelstreng en foetale Placenta

Isolatie en identificatie van mesenchymale stamcellen afgeleid van vetweefsel van Sprague Dawley-ratten

Isolatie, in-vitro-expansie en karakterisering van mesenchymale stamcellen uit epididymaal vetweefsel van muizen

Transplantatie van geïnduceerde pluripotente stamcel-afgeleide mesoangioblast-achtige myogene voorlopers in muismodellen van spierregeneratie

Systemische Injectie van neurale stamcellen / progenitorcellen in Muizen met chronische EAE

Hoge doorvoer analyse van volwassen stamcellen ontwikkeld voor toediening van therapeutische factoren voor Neuroprotective Strategies

Differentiatie van een menselijke neurale stamcellen Line op Three Dimensional Culturen, Analyse van MicroRNA en vermeende doelwit-genen

Hypoxische preconditioning van merg-afgeleide progenitorcellen als bron voor de generatie van volwassen Schwann-cellen

Intranasale Levering van Therapeutische Stamcellen aan Glioblastoma in een Muis Model

Image-Guided resectie van Glioblastoma en intracraniële implantatie van therapeutische stamcel-geplaatste steigers